Orphan Drugs
Orphan drugs are medications developed under a special program that assists the manufacturers of products needed to treat a potential patient population that is too small for profitable drug research, development, and marketing. Orphan drugs provide important breakthroughs for patients who would otherwise be left lacing therapy.
Featured Products
![](https://static.complianceonline.com/images/newUI/images/docu_img.jpg)
Optimal Clinical Supply Planning for Global Drug Development
Online training - supply chain risk - optimize clinical trial supply - risk management - supply simulation tool
Online training - supply chain risk - optimize clinical trial supply - risk management - supply simulation tool
Biomarkers for Drug Development: The Emerging Regulatory Landscape
Regulatory requirements - biomarkers development and implementation - drug development programs - PET Drugs - FDA guidelines
Regulatory requirements - biomarkers development and implementation - drug development programs - PET Drugs - FDA guidelines
Drug Safety Assessment and Risk Minimization in the Development Period
Drug safety training - factors to be considered - drug development - risk management - intellectual property - pharmacovigilance
Drug safety training - factors to be considered - drug development - risk management - intellectual property - pharmacovigilance